Clinical Trial: Role of CCL2 in Alcoholic Liver Diseases

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title:

Brief Summary: Immune dysregulations, including cytokines and chemokines secretions occurs in alcoholic liver disease. Serum levels and liver expression of CCL2 are increased in patients with alcoholic hepatitis but the role of this chemokine in the pathogenesis of alcoholic liver disease is nevertheless unknown. The aim of the study is to analyze plasma level and liver expression of CCL2 and their relation with liver disease severity and inflammatory infiltrate in our cohort of alcoholic patients. We studied also the association between -2518 CCL2 polymorphism and the severity of alcoholic liver disease.

Detailed Summary:
Sponsor: Erasme University Hospital

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Erasme University Hospital

Dates:
Date Received: May 20, 2010
Date Started:
Date Completion:
Last Updated: May 20, 2010
Last Verified: December 2002